Feeling the pressure: nanoparticle crystallization using controlled expansion of supercritical solutions
Nanoforming improves bioavailabiliy by increasing the specific surface area of…
Financial Hearings webcast presentation at 15.00 EET
Report and presentation: https://nanoform.com/en/nanoform-q3-2023-nanoformed-blockbuster-drug-enters-clinic-and-another-nanoformed-drug-received-fda-orphan-designation/ Webcast: https://ir.financialhearings.com/nanoform-q3-report-2023 Telephone conference: https://conference.financialhearings.com/teleconference/?id=5005133
Invitation to Nanoform’s Q3 2023 Interim Report
Press release Nanoform Finland Plc November 8, 2023 11:00 a.m.…
Nanoform grant Global STARMAP[®] AI License to AstraZeneca
Press release Nanoform Finland Plc October 23, 2023 08:10 Finnish…
Nanoformed TargTex oncology drug candidate TTX101 receives FDA Orphan Drug Designation
Press release Nanoform Finland Plc October 19, 2023 12:15 Finnish…
